The week in health tech, explained in plain English.Get the free newsletter →
October 23, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Vertical Integration Is Quietly Inflating Patient Bills

Healthcare's biggest players increasingly own every link in the chain, and patients are paying for it, KFF Health News reports. Hospitals buy physician practices and outpatient facilities. Insurers own pharmacies and pharmacy benefit managers. That consolidation, known as vertical integration, quietly reshapes where care happens and what it costs.

In practice, a patient sent for a routine procedure may be routed to a hospital-owned site that charges far more than an independent clinic for the same service, adding thousands to a bill. Someone filling a prescription may be steered to their insurer's wholly owned pharmacy, which may not stock the prescribed drug or offer the lowest price. The financial incentives favor the integrated company, not the patient.

Because these arrangements are legal and largely invisible on an itemized bill, patients rarely see the markup or the steering. The trend has drawn scrutiny from regulators and lawmakers, but the underlying business model continues to expand across hospitals, insurers, and drug supply chains.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.